Please assess the completion status of the following clinical trial:

Trial Title: The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* • Grand multipara~  * Multiple pregnancy~ * Polyhydraminos (AFI is more than 24 cm).~ * Placenta previa~ * Gestational diabetes mellitus~ * Preeclampsia~ * Anemia complicating pregnancy (Hemoglobin is less than 11 gm/dl)~Exclusion Criteria:~* • Allergy to tranxemic acid.~  * H/o suggestive of bleeding disorders~ * previous history of deep vein thrombosis~ * Abnormally invasive placenta~ * Emergency cesarean sections~ * Intraoprative complications during cesarean sections as uterine artery injury and broad ligamentary hematoma.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Tranexamic acid group (Type: ACTIVE_COMPARATOR): 1 g (10 mL) tranexamic acid (Kapron, Amoun, Egypt; stored in a dry container at 15 °C-30 °C) diluted in 20 mL of 5% glucose slowly administered intravenously 15 minutes before skin incision over a 5-minute period.
- Control group (Type: PLACEBO_COMPARATOR): 30 mL of 5% glucose slowly administered intravenously 15 minutes before skin incision over a 5-minute period.

Based on this trial design, predict the completion outcome and termination type (if applicable).